Abstract:Introduction: Breast cancer is the most common neoplasm in women around the world. There are several risk factors for this cancer: sex, age, body mass index (BMI), hormone therapy, family history, genetic mutations, among several others. The vast majority of breast tumors are characterized as carcinomas and may originate from ducts or lobules. Immunohistochemistry is related to the expressions of the estrogen receptor (ER) and progesterone receptor (PR), as well as the expression of the human epidermal growth factor receptor 2 (HER2), cell proliferation or the absence of any expression from receptors on the tumor membrane. The telomeres protect the chromosomes natural endings from suffering DNA loss. Telomerase is a ribonuclear protein complex (RNA and protein) that neutralizes telomeres' shortening. Recurrent point mutations in the TERT telomerase promoter have been identified in several cancers, and the rs2242652 polymorphism is a single nucleotide change, and has been described as associated with breast cancer risk. Objective: The objective of this study is to analyze the TERT rs2242652 polymorphism in breast cancer women and to test the correlation of such data with the prognosis and various clinical variables. Methods: The study was conducted as an observational clinical study of women with breast cancer. A blood sample was collected from the patient and PCR was performed to extract the DNA and to analyze the telomerase polymorphisms in this population. To ensure a more descriptive analysis, the data was used in the construction of tables and graphs, that were then studied in a qualitative manner. The associations were analyzed through direct correlation tests and were followed by comparisons of categorization groups. Results and discussion: Fifty-four women presented polymorphism of the telomerase hTERT gene rs2242652. They were divided into two groups according to the A or G allele that confer the GA/AA and GG gene variants. It was found that the GA/AA group had a trend towards more aggressive tumors, presenting 33% triple negative and 22% of tumors with HER2 overexpression, different from the GG group: 19% triple negative and 10% HER2 overexpression. More aggressive T4 tumors, were more expressive in the GA/AA gene variant group representing 20% of the patients, whereas in the GG group they represented only 8%. Conclusion: The data found in this study on the telomerase TERT gene polymorphism rs2242652 with breast cancer refers to a tendency found in tumors that have a more severe prognosis, to associate with the gene variant linked to the A allele of this gene, however a larger sample number is required for statistical confirmation. Citation Format: Miriam Alvares, Elisa Mascarenhas, Joao Matos. rs2242652 POLYMORPHISM OF THE hTERT GENE IN WOMEN WITH BREAST CANCER [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl) nr PO5-25-09.

Association between human telomerase reverse transcriptase (hTERT) MNS16A polymorphism and risk of breast cancer

A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women.

Mns16a Tandem Repeats Minisatellite Of Human Telomerase Gene And Cancer Risk: A Meta-Analysis

Htert MNS16A Genotype and Breast Cancer Susceptibility in Sister-Pairs

The TERT MNS16A polymorphism contributes to cancer susceptibility: meta-analysis of the current studies.

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Abstract PO5-25-09: rs2242652 POLYMORPHISM OF THE hTERT GENE IN WOMEN WITH BREAST CANCER

Telomere reverse transcriptase (TERT) rs2735940 increases cancer risk.

Dual Roles of a Variable Number of Tandem Repeat Polymorphism in the TERT Gene in Lung Cancer.

A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population

Association Between Tert Rs2853669 Polymorphism And Cancer Risk: A Meta-Analysis Of 9,157 Cases And 11,073 Controls

hTERT Cancer Risk Genotypes Are Associated With Telomere Length

Association Between the TERT Genetic Polymorphism Rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls.

Genetic regulation of TERT splicing contributes to reduced or elevated cancer risk by altering cellular longevity and replicative potential

The TERT rs2736100 Polymorphism and Cancer Risk: A Meta-analysis Based on 25 Case-Control Studies

Association of Genetic Polymorphisms in the Telomerase Reverse Transcriptase Gene with Prostate Cancer Aggressiveness

Association between the telomerase reverse Transcriptase ( TERT ) rs 2736098 polymorphism and cancer risks : a meta-analysis

Association of single nucleotide polymorphism of hTERT candidate genes with gastric carcinoma

The TERT Rs2736100 Polymorphism and Susceptibility to Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis.

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

The TERT Promoter Mutation Incidence is Modified by Germline TERT Rs2736098 and Rs2736100 Polymorphisms in Hepatocellular Carcinoma